Mariner’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163K Buy
10,925
+177
+2% +$2.59K ﹤0.01% 3213
2025
Q4
$143K Sell
10,748
-3,598
-25% -$52.6K ﹤0.01% 3256
2025
Q3
$226K Sell
14,346
-523
-4% -$8.61K ﹤0.01% 3068
2025
Q2
$224K Buy
14,869
+1,900
+15% +$27.8K ﹤0.01% 2961
2025
Q1
$195K Sell
12,969
-974
-7% -$14.4K ﹤0.01% 3019
2024
Q4
$201K Buy
13,943
+354
+3% +$6.32K ﹤0.01% 3002
2024
Q3
$263K Buy
13,589
+78
+0.6% +$1.41K ﹤0.01% 2688
2024
Q2
$232K Buy
13,511
+1,155
+9% +$21.3K ﹤0.01% 2660
2024
Q1
$208K Buy
12,356
+1,078
+10% +$16.4K ﹤0.01% 2737
2023
Q4
$204K Buy
11,278
+1,229
+12% +$22.3K ﹤0.01% 2683
2023
Q3
$170K Buy
+10,049
New +$144K ﹤0.01% 2565
2023
Q2
Sell
-11,325
Closed -$148K 2868
2023
Q1
$148K Buy
11,325
+200
+2% +$3.28K ﹤0.01% 2485
2022
Q4
$164K Buy
+11,125
New +$122K ﹤0.01% 2401

Other funds holding HCM

Mariner's HCM Position: Q1 2026 in Review

Mariner increased its HUTCHMED (HCM) stake by 1.6% in Q1 2026, buying an estimated $2.59K and bringing the position to 10,925 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

Mariner first reported a position in HCM in Q4 2022 and has held it in 13 quarters since. The position peaked at $263K in Q3 2024. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Mariner held 10,925 shares of HUTCHMED worth $163K as of Q1 2026.
  • Mariner bought 177 HUTCHMED shares in Q1 2026, an estimated $2.59K.
  • HUTCHMED made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3213 holding.
  • Mariner first reported a position in HUTCHMED in Q4 2022 and has held it in 13 quarters since.
  • Mariner's HUTCHMED position peaked at $263K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.